These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 19656071)
1. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood. Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071 [TBL] [Abstract][Full Text] [Related]
2. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood]. Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768 [TBL] [Abstract][Full Text] [Related]
4. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. Shaw PH; Olszewski M; Kletzel M J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314 [TBL] [Abstract][Full Text] [Related]
5. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951 [TBL] [Abstract][Full Text] [Related]
6. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328 [TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood. Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture]. Hao SG; Sun GL; Wu WL; Wu YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136 [TBL] [Abstract][Full Text] [Related]
10. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells]. Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679 [TBL] [Abstract][Full Text] [Related]
11. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164 [TBL] [Abstract][Full Text] [Related]
12. [Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells]. Zhang JX; Mao P Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):429-33. PubMed ID: 15972135 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
14. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674 [TBL] [Abstract][Full Text] [Related]
15. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells. Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761 [TBL] [Abstract][Full Text] [Related]
16. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081 [TBL] [Abstract][Full Text] [Related]
17. IL-6 precludes the differentiation induced by IL-3 on expansion of CD34+ cells from cord blood. Encabo A; Mateu E; Carbonell-Uberos F; Miñana MD Haematologica; 2003 Apr; 88(4):388-95. PubMed ID: 12681965 [TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored. Ruggieri L; Heimfeld S; Broxmeyer HE Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350 [TBL] [Abstract][Full Text] [Related]
19. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients. Filip S; Vávrová J; Vokurková D; Bláha M; Vanásek J Neoplasma; 2000; 47(2):73-80. PubMed ID: 10985471 [TBL] [Abstract][Full Text] [Related]
20. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells. Reems JA; Mielcarek M; Torok-Storb B Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]